ZA949843B - Pharmaceutical formulation for the prophylaxis and pretreatment of a poisoning caused by organophosphorus cholinesterase inhibitors - Google Patents

Pharmaceutical formulation for the prophylaxis and pretreatment of a poisoning caused by organophosphorus cholinesterase inhibitors

Info

Publication number
ZA949843B
ZA949843B ZA949843A ZA949843A ZA949843B ZA 949843 B ZA949843 B ZA 949843B ZA 949843 A ZA949843 A ZA 949843A ZA 949843 A ZA949843 A ZA 949843A ZA 949843 B ZA949843 B ZA 949843B
Authority
ZA
South Africa
Prior art keywords
prophylaxis
pharmaceutical formulation
cholinesterase inhibitors
pretreatment
pct
Prior art date
Application number
ZA949843A
Other languages
English (en)
Inventor
Thomas Hille
Bodo Asmussen
Yacov Meshulam
Walter Mueller
Aharon Levy
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6504683&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA949843(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of ZA949843B publication Critical patent/ZA949843B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Addiction (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ZA949843A 1993-12-10 1994-12-09 Pharmaceutical formulation for the prophylaxis and pretreatment of a poisoning caused by organophosphorus cholinesterase inhibitors ZA949843B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4342173A DE4342173A1 (de) 1993-12-10 1993-12-10 Pharmazeutische Formulierung zur Prophylaxe bzw. Vorbehandlung einer Vergiftung durch phosphororganische Cholinesterasehemmer

Publications (1)

Publication Number Publication Date
ZA949843B true ZA949843B (en) 1995-09-01

Family

ID=6504683

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA949843A ZA949843B (en) 1993-12-10 1994-12-09 Pharmaceutical formulation for the prophylaxis and pretreatment of a poisoning caused by organophosphorus cholinesterase inhibitors

Country Status (22)

Country Link
US (1) US6114347A (fr)
EP (1) EP0732926B1 (fr)
JP (1) JP3709204B2 (fr)
KR (1) KR100374086B1 (fr)
AT (1) ATE232726T1 (fr)
AU (1) AU704020B2 (fr)
CA (1) CA2178605C (fr)
CZ (1) CZ291870B6 (fr)
DE (2) DE4342173A1 (fr)
DK (1) DK0732926T3 (fr)
ES (1) ES2193185T3 (fr)
FI (1) FI962369A (fr)
HU (1) HUT74427A (fr)
IL (1) IL111917A (fr)
MY (1) MY116828A (fr)
NO (1) NO962406L (fr)
NZ (1) NZ277258A (fr)
PL (1) PL314915A1 (fr)
PT (1) PT732926E (fr)
SK (1) SK282536B6 (fr)
WO (1) WO1995015756A1 (fr)
ZA (1) ZA949843B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2170649B1 (es) * 2000-03-29 2003-06-16 Ferrer Int Uso de la cdp-colina en el tratamiento de la abstinencia alcoholica.
WO2002092003A2 (fr) * 2001-05-11 2002-11-21 Bacaner Marvin B Nouvelles compositions d'ammonium quaternaire couplees avec des anions auxiliaires, utilisations de celles-ci dans des kits et utilisation de celles-ci pour prevenir et traiter certaines pathologies
GB2405336A (en) * 2002-05-01 2005-03-02 Eisai Co Ltd Cholinesterase inhibitors to prevent injuries caused by chemicals
DE10301851A1 (de) * 2003-01-17 2004-07-29 Lts Lohmann Therapie-Systeme Ag Verfahren zur medikamentösen Prophylaxe gegen Vergiftungen durch Cholinesterase-Hemmer, sowie hierfür geeignete Wirkstoffe und Arzneimittel
US20050013869A1 (en) * 2003-07-18 2005-01-20 Chaw Cheng Shu Sustained release formulation for carbamates and a method therefor
EP1663203A1 (fr) * 2003-09-19 2006-06-07 The Secretary of State for Defence Compositions pharmaceutiques destinees au traitement d'un empoisonnement par un organophosphate
US9308164B2 (en) 2004-06-30 2016-04-12 Sovereign Pharmaceuticals, Llc Hyoscyamine dosage form
AU2005289808B2 (en) * 2004-09-24 2011-11-03 The Government Of The United States As Represented By The Secretary Of The Army, U.S. Army Medical Research Institute Of Chemical Defense Method of treating organophosphorous poisoning
US9132135B2 (en) * 2004-09-24 2015-09-15 University Of Maryland, Baltimore Method of treating organophosphorous poisoning
CN111773389A (zh) * 2020-06-02 2020-10-16 杨卫国 一种治疗牛中毒的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3760805A (en) * 1971-01-13 1973-09-25 Alza Corp Osmotic dispenser with collapsible supply container
US3760806A (en) * 1971-01-13 1973-09-25 Alza Corp Helical osmotic dispenser with non-planar membrane
US3764984A (en) * 1972-01-28 1973-10-09 Benz G Information coding system
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US3987790A (en) * 1975-10-01 1976-10-26 Alza Corporation Osmotically driven fluid dispenser
US4137300A (en) * 1976-08-20 1979-01-30 Ciba-Geigy Corporation Sustained action dosage forms
ZA796519B (en) * 1978-12-01 1980-11-26 Pfizer Preparation of 2-ketogulonic acid
JPS60189744A (ja) * 1984-03-09 1985-09-27 Tokyo Color:Kk カラ−写真現像液の再生方法
JPS62133457A (ja) * 1985-12-04 1987-06-16 Konishiroku Photo Ind Co Ltd ハロゲン化銀カラ−写真感光材料の処理方法及び現像液処理装置
JPH03194552A (ja) * 1989-12-22 1991-08-26 Fuji Photo Film Co Ltd ハロゲン化銀カラー写真感光材料の処理方法
US5278035A (en) * 1990-01-31 1994-01-11 Knapp Audenried W Non-toxic photographic developer composition for processing x-ray films in automatic film processors
US5098819A (en) * 1990-01-31 1992-03-24 Knapp Audenried W Non-toxic photographic developer composition
DE4115558A1 (de) * 1991-05-13 1992-11-19 Dresden Arzneimittel Prophylaktisches antidot gegen phosphororganische gifte

Also Published As

Publication number Publication date
NO962406D0 (no) 1996-06-07
KR100374086B1 (ko) 2003-07-23
EP0732926A1 (fr) 1996-09-25
FI962369A0 (fi) 1996-06-07
KR960706341A (ko) 1996-12-09
IL111917A (en) 1998-08-16
JPH09506361A (ja) 1997-06-24
WO1995015756A1 (fr) 1995-06-15
DE59410246C5 (de) 2008-09-25
CA2178605C (fr) 2006-02-14
CZ291870B6 (cs) 2003-06-18
US6114347A (en) 2000-09-05
EP0732926B1 (fr) 2003-02-19
ATE232726T1 (de) 2003-03-15
IL111917A0 (en) 1995-03-15
DK0732926T3 (da) 2003-06-10
CA2178605A1 (fr) 1995-06-15
AU1242495A (en) 1995-06-27
DE4342173A1 (de) 1995-06-14
DE59410246D1 (de) 2003-03-27
AU704020B2 (en) 1999-04-15
NO962406L (no) 1996-06-07
FI962369A (fi) 1996-08-02
MY116828A (en) 2004-04-30
SK73896A3 (en) 1996-12-04
PT732926E (pt) 2003-06-30
ES2193185T3 (es) 2003-11-01
NZ277258A (en) 1999-09-29
HU9601599D0 (en) 1996-08-28
SK282536B6 (sk) 2002-10-08
JP3709204B2 (ja) 2005-10-26
HUT74427A (en) 1996-12-30
PL314915A1 (en) 1996-09-30
CZ168396A3 (en) 1996-10-16

Similar Documents

Publication Publication Date Title
IL111942A0 (en) A transdermal therapeutic system containing a parasympathomimetic compound and a parasympatholytic compound
ES2128552T3 (es) Combinacion de un inhibidor de la biosintesis del colesterol y un inhibidor de la absorcion del colesterol beta-lactama.
IL94990A (en) Pharmaceutical compositions for the prophylaxis and/or treatment of benign porstatic hyperplasia
AU8060494A (en) Plaster for treating nail mycoses
MX9306295A (es) Composiciones farmaceuticas para tratar sintomas de resfriado.
ZA949843B (en) Pharmaceutical formulation for the prophylaxis and pretreatment of a poisoning caused by organophosphorus cholinesterase inhibitors
ZA922297B (en) Crystalline tiababine monohydrate,its preparation and use
HU9601684D0 (en) Deuterised active agents in transdermal application
PL327818A1 (en) Novel medical application of ace inhibitor in treating dipeptic symptoms
AU7439996A (en) Novel uses of mammalian ctla-8 and related reagents
GR3034142T3 (en) Composition for the treatment or prevention of herpes